Atrial Fibrillation Treatment Stratification Based on Artificial Intelligence‐Driven Analysis of the Electrophysiological Complexity
Journal of Cardiovascular Electrophysiology · 2025
DOI: 10.1111/jce.16754 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von Ana María Sánchez de la Nava und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. Hauptthemen laut MEDLINE: Atrial Fibrillation, Action Potentials, Heart Rate, Anti-Arrhythmia Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was funded by the Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Ministerio de Ciencia e Inn…, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Background
Atrial Fibrillation (AF) treatment strategies are suboptimal and clinical predictors of success are limited. Artificial Intelligence (AI) has arisen as a powerful tool for treatment efficacy prediction.
Objective
We developed an AI‐driven platform for the stratification of patients based on noninvasive Electrocardiographic Imaging (ECGI) biomarkers and clinical parameters to evaluate and predict optimal patient treatment.
Methods
We evaluated 204 patients treated according to clinical guidelines and characterized them at the electrophysiological level using ECGI recordings during AF. ECGI signals were calculated to obtain frequency and rotational biomarkers. Baseline clinical characteristics and treatment after inclusion were registered.
Results
A clustering algorithm was calibrated taking three different variables for 1 year outcome prediction: (1) AF type (paroxysmal or persistent); (2) ECGI complexity score (calculated based on highest dominant frequency, median dominant frequency, and mean rotor time); and (3) type of treatment: rhythm control (drugs, AF ablation) or rate control. The cluster analysis classified patients into five groups: Low electrophysiological complexity patterns were associated with an improved outcome after ablation, regardless of the time duration of the AF. Intermediate complexity scores in paroxysmal AF had a favourable outcome with rhythm control treatments, but not in persistent AF patients. Cluster patterns with higher electrophysiological complexity were associated with a higher probability of AF recurrence, both in paroxysmal and persistent groups. The performance of the algorithm predicting the outcome was (AUC: 0.73 (0.63–0.81)), increasing overall performance with respect to conventional persistent and paroxysmal classification (AUC: 0.58 (0.48–0.68); p < 0.05). This algorithm was evaluated on the 20% test set, obtaining 90% prediction success.
Conclusions
AI‐driven analysis that combined clinical information with ECGI biomarkers increased the performance of conventional classification methods for AF treatment stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
- CIBERCV, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares, Spain.
- ITACA, Universitat Politècnica de València, Valencia, Spain.
- Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.
- Corify Care SL, Madrid, Spain.
ORCID-Profile: Ana María Sánchez de la Nava, Alejandro Carta, Esteban González-Torrecilla
Förderung
- This study was funded by the Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Ministerio de Ciencia e Inn…
- Instituto de Salud Carlos III
Zitieren
APA
de la Nava, A. M. S., Ros, S., Carta, A., González-Torrecilla, E., Mansilla, A. G., Bermejo, J., Arenal, Á., Climent, A. M., Guillem, M. S., Atienza, F., & Other Members of the STRATIFY Study Group (2025). Atrial Fibrillation Treatment Stratification Based on Artificial Intelligence‐Driven Analysis of the Electrophysiological Complexity. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16754
Vancouver
de la Nava AMS, Ros S, Carta A, González-Torrecilla E, Mansilla AG, Bermejo J, et al. Atrial Fibrillation Treatment Stratification Based on Artificial Intelligence‐Driven Analysis of the Electrophysiological Complexity. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.16754
BibTeX
@article{delaNava2025,
author = {de la Nava, Ana María Sánchez and Ros, Santiago and Carta, Alejandro and González-Torrecilla, Esteban and Mansilla, Ana González and Bermejo, Javier and Arenal, Ángel and Climent, Andreu M and Guillem, María S and Atienza, Felipe and Other Members of the STRATIFY Study Group, Other Members of the STRATIFY Study Group},
title = {Atrial Fibrillation Treatment Stratification Based on Artificial Intelligence‐Driven Analysis of the Electrophysiological Complexity},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2025},
doi = {10.1111/jce.16754}
}
EUVIMED